ARCHIVES

Pazdur: Registration Trials Run By Groups Need Same Rigor As Industry Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Report On Carcinogenesis Testing, Evaluation Submitted to NTP; Calls For Continued Research

September 7, 1984

Capizzi Succeeds Spurr as Director Of Bowman Gray Cancer Center

September 10, 1982

Komen Brand Takes Hit After PR Disaster

March 30, 2012

Hammond Resigns As Director Of USC Comp Center

May 29, 1981

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004